¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ´ëÀåÇ×¹®ÇÐȸ Á¦ 55Â÷ Ãá°è Çмú´ëȸ(2ÀÏÂ÷) : 2022-04-09

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ´ëÀåÇ×¹®ÇÐȸ Á¦ 55Â÷ Ãá°è Çмú´ëȸ(2ÀÏÂ÷) : 2022-04-09
±³À°ÀÏÀÚ : 2022-04-09
±³À°Àå¼Ò : ½Ã±×´Ï¿¤ ºÎ»ê  
±³À°ÁÖÁ¦ : ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ Á¦ 55Â÷ Ãá°è Çмú´ëȸ(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ
´ã´çÀÚ : ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ
¿¬¶ôó : 02-2040-7736  
À̸ÞÀÏ : colon@kams.or.kr      
±³À°Á¾·ù : ¿Ü°úÀÇÇб³À°
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 250,000¿ø      
ºñ°í [»çÀüµî·Ï] Æò»ýȸ¿ø : 10¸¸¿ø (ÇÏ·çµî·Ï : 7¸¸¿ø) Á¤È¸¿ø : 15¸¸¿ø (ÇÏ·çµî·Ï : 10¸¸¿ø) ºñȸ¿ø : 20¸¸¿ø (ÇÏ·çµî·Ï : 15¸¸¿ø)  [ÇöÀåµî·Ï] Æò»ýȸ¿ø : 15¸¸¿ø (ÇÏ·çµî·Ï : 12¸¸¿ø) Á¤È¸¿ø : 20¸¸¿ø (ÇÏ·çµî·Ï : 15¸¸¿ø) ºñȸ¿ø : 25¸¸¿ø (ÇÏ·çµî·Ï : 20¸¸¿ø)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-09 Room 1 08:00~08:20 Optimal care in high cardiovascular risk patients  ¹ÚÇö¿ì(¼øõÇâÀÇ´ë ½ÉÀå³»°ú) 
±³À°½Ã°£ 04-09 Room 1 08:20~08:40 Strategy after unavoidable surgery in ECOG II-III patients: prevention and rehabilitation  Àü¿ë°ü(¿¬¼¼´ë ½ºÆ÷Ã÷ÀÀ¿ë»ê¾÷Çаú) 
±³À°½Ã°£ 04-09 Room 1 08:40~09:00 Perioperative care in liver cirrhosis patients  ÀÓÂ÷¹Ì(¼­¿ïÀÇ´ë ¿Ü°ú) 
±³À°½Ã°£ 04-09 Room 1 09:00~09:20 Peri/postoperative fluid therapy in ESRD patients  À¯º´Ã¶(¼øõÇâÀÇ´ë ³»°ú) 
±³À°½Ã°£ 04-09 Room 1 09:20~09:40 To better adherence to ERAS elements after rectal cancer surgery  ¿ÀÈï±Ç(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-09 Room 1 09:40~10:00 Case presentation, voting and panel discussion  ¹ÌÁ¤() 
±³À°½Ã°£ 04-09 Room 1 10:00~10:10 First choice: surgical resection  Çϱâ¿ø(ÀüºÏÀÇ´ë) 
±³À°½Ã°£ 04-09 Room 1 10:10~10:20 First choice: chemotherapy  ±è¼±¿µ(¿ï»êÀÇ´ë Á¾¾ç³»°ú) 
±³À°½Ã°£ 04-09 Room 1 10:20~10:30 Radiation oncologist  °­¹Î±Ô(°æºÏÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú) 
±³À°½Ã°£ 04-09 Room 1 10:30~10:40 Evaluation of response after chemoradiotherapy  ¹®¼º°æ(°æÈñÀÇ´ë ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 04-09 Room 1 10:40~10:50 Liver metastasis: hepatectomy vs RFA  ±èÁöÈÆ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 04-09 Room 1 10:50~11:00 Policy for cCR in image studies  ÀÌ°æÇÏ(Ãæ³²ÀÇ´ë) 
Åä·Ð 04-09 Room 1 11:00~11:20 Panel discussion  () 
±³À°½Ã°£ 04-09 Room 1 14:10~14:30 Effective strategies for colorectal cancer screening for young people  Á¤À±¼÷(¼º±Õ°üÀÇ´ë ¼ÒÈ­±â³»°ú) 
±³À°½Ã°£ 04-09 Room 1 14:30~14:50 Oncofertility preservation policy in female patients  ¹ÚÇöÅÂ(°í·ÁÀÇ´ë »êºÎÀΰú) 
±³À°½Ã°£ 04-09 Room 1 14:50~15:10 Oncofertility preservation policy in male patients  ¼Û½ÂÈÆ(Â÷ÀÇ°úÇÐ´ë ºñ´¢ÀÇÇаú) 
±³À°½Ã°£ 04-09 Room 1 15:10~15:30 Psyco oncology in young patients  ¿ø±ÙÈñ(¼­¿ïÀÇ´ë Á¤½Å°Ç°­ÀÇÇаú) 
±³À°½Ã°£ 04-09 Room 1 15:30~15:50 Genetic counseling and surveillance of secondary malignancy  ±èÅÂÀÏ(¿¬¼¼ÀÇ´ë ¼ÒÈ­±â³»°ú) 
±³À°½Ã°£ 04-09 Room 1 15:50~16:10 Molecular tumor boards in metastatic CRC: fallacy and hurdles  ±èÁö¿ø(¼­¿ïÀÇ´ë Ç÷¾×Á¾¾ç³»°ú) 
±³À°½Ã°£ 04-09 Room 1 16:10~16:30 Management for liver vs lung metastasis: similarity and difference  °èºÀÇö(°¡Å縯 ÀÇ´ë) 
±³À°½Ã°£ 04-09 Room 1 16:30~16:50 Palliative care for headache in brain metastases: Metastasectomy  ¾ç½ÂÈ£(°¡Å縯ÀÇ´ë ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 04-09 Room 1 16:50~17:10 Palliative care in lung metastases: Stereotactic ablative radiotherapy (SABR)  ÀåÁö¼®(¿¬¼¼ÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú) 
±³À°½Ã°£ 04-09 Room 1 17:10~17:30 Intensive chemotherapy and treatment holiday for symptomatic care  À±Áø¾Æ(¼øõÇâÀÇ´ë Á¾¾çÇ÷¾×³»°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ Á¦ 55Â÷ Ãá°è Çмú´ëȸ(2ÀÏÂ÷) : 2022-04-09""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2022³âµµ ´ëÇÑÅëÁõÇÐȸ ÃÊÀ½ÆÄ ¿¬¼ö°­Á II(2ÀÏÂ÷) : 2022-04-10
´ÙÀ½±Û (¿Â¶óÀÎ) 2022³âµµ Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ÀΰÝÀå¾Ö Á¤½ÅÄ¡·á ¿öÅ©¼¥ 2 : 2022-04-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 124 2024-05-28
20896 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 208 2024-05-28
20895 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 163 2024-05-28
20894 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 72 2024-05-28
20893 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 91 2024-05-28
20892 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 52 2024-05-28
20891 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 83 2024-05-28
20890 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 183 2024-05-27
20889 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 118 2024-05-27
20888 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 250 2024-05-27
20887 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 118 2024-05-27
20886 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 57 2024-05-27
20885 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 57 2024-05-27
20884 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 98 2024-05-27
20883 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 92 2024-05-27
21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷